<unk>  newly affected about 44,200 people and resulted in 15,200 deaths globally in 2018.<unk>  can be split up into two types. One starts as an infection by human papillomavirus, which leads to<unk>  intraepithelial neoplasia (VIN) and potentially on to<unk> . This is most common in younger women, predominantly under the age of 40. The second type is<unk>  non-neoplastic epithelial disorders (VNED). This is most common in older women, due to the increased risk for developing cellular atypia which in turn leads to cancer. United Kingdom<unk>  causes less than 1% of all cancer cases and deaths but around 6% of all gynecologic cancers diagnosed in the UK. Around 1,200 women were diagnosed with the disease in 2011, and 400 women died in 2012. In the United Kingdom 7 out of 10<unk>  patients have major surgical resection as part of their cancer treatment. 22% of patients use radiotherapy and only 7% use chemotherapy as a treatment plan. There are very high survival rates, patients diagnosed with<unk>  have an 82% of living more than one year, a 64% chance of living at least 5 years and a 53% chance of living ten or more years. The rate of survival increases dependent on age of patient and the stage the cancer was found in. United States In the United States, it newly occurred in about 6,070 people with 1,280 deaths a year. It makes up about 0.3% of new cancer cases, and 5% of gynecologic cancers in the United States.<unk>  cases have been rising in the United States at an increase of 0.6% each year for the past ten years.
Vulvar cancer
Lichen sclerosus
Genital ulcer
Hyperplasia
Amurca
Bartholin's cyst
Anal cancer
Atrophic vaginitis